Citation Impact
Citing Papers
Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration
2005 StandoutScience
Sphingosine 1-Phosphate Activates Akt, Nitric Oxide Production, and Chemotaxis through a GiProtein/Phosphoinositide 3-Kinase Pathway in Endothelial Cells
2001
Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy
2004 Standout
S-Nitrosylation of β-Arrestin Regulates β-Adrenergic Receptor Trafficking
2008 StandoutNobel
Reduced maternal expression of adrenomedullin disrupts fertility, placentation, and fetal growth in mice
2006 StandoutNobel
The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis
2005 StandoutNobel
MYC on the Path to Cancer
2012 Standout
Nitric oxide synthases: regulation and function
2011 Standout
Statins and the Myocardium
2004
AKT/PKB Signaling: Navigating Downstream
2007 Standout
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes
2005 Standout
HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway
2001
mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery
2002 Standout
Adrenomedullin Promotes Proliferation and Migration of Cultured Endothelial Cells
2003
Increased skeletal VEGF enhances β‐catenin activity and results in excessively ossified bones
2009
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
2002 Standout
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies
2008
Expression of Vascular Endothelial Growth Factor Receptor 1 in Bone Marrow-derived Mesenchymal Cells Is Dependent on Hypoxia-inducible Factor 1
2006 StandoutNobel
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
2006 Standout
Tie2/Angiopoietin-1 Signaling Regulates Hematopoietic Stem Cell Quiescence in the Bone Marrow Niche
2004 Standout
Age-Related Macular Degeneration: Etiology, Pathogenesis, and Therapeutic Strategies
2003
Isoprenoids as mediators of the biological effects of statins
2002
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
2010
Regulation of β-Adrenergic Receptor Signaling by S-Nitrosylation of G-Protein-Coupled Receptor Kinase 2
2007 StandoutNobel
Statin effects beyond lipid lowering—are they clinically relevant?
2003
Akt1/protein kinase B is critical for ischemic and VEGF-mediated angiogenesis
2005
Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis?
2004
Stabilization of atherosclerotic plaques: New mechanisms and clinical targets
2002
New directions for protecting the heart against ischaemia–reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway
2003
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
2013 Standout
Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection
2007
β-Arrestin1 Mediates Insulin-like Growth Factor 1 (IGF-1) Activation of Phosphatidylinositol 3-Kinase (PI3K) and Anti-apoptosis
2003 StandoutNobel
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
Atorvastatin, administered at the onset of reperfusion, and independent oflipid lowering, protects the myocardiumby up-regulating a pro-survival pathway
2003
Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular Risk
2003 Standout
Promotion of airway anastomotic microvascular regeneration and alleviation of airway ischemia by deferoxamine nanoparticles
2013 StandoutNobel
Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone
2014 StandoutNature
HMG-CoA reductase inhibitor mobilizes bone marrow–derived endothelial progenitor cells
2001
Myocardial Reperfusion Injury
2007 Standout
Pleiotropic effects of statin therapy: molecular mechanisms and clinical results
2008
Transcoronary Transplantation of Progenitor Cells after Myocardial Infarction
2006 Standout
Reactive oxygen species have a causal role in multiple forms of insulin resistance
2006 StandoutNature
Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling
2010
The receptor tyrosine kinase inhibitor SU11248 impedes endothelial cell migration, tubule formation, and blood vessel formation in vivo, but has little effect on existing tumor vessels
2004
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Phosphoinositides in cell regulation and membrane dynamics
2006 StandoutNature
AKT/PKB Signaling: Navigating the Network
2017 Standout
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Points of control in inflammation
2002 StandoutNature
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Calcium Signaling
2007 Standout
VEGF Inhibition and Renal Thrombotic Microangiopathy
2008 Standout
Targeting eNOS for stroke protection
2004
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
2004 Standout
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
2011 StandoutNature
Decreased vascular lesion formation in mice with inducible endothelial-specific expression of protein kinase Akt
2006
Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy
2001
Endothelial Progenitor Cells and Vascular Biology in Diabetes Mellitus: Current Knowledge and Future Perspectives
2005
Fluorine in medicinal chemistry
2007 Standout
HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway
2001
HMG-CoA reductase inhibitor mobilizes bone marrow–derived endothelial progenitor cells
2001
Isoprenoids as mediators of the biological effects of statins
2002
Endothelial PAS Domain Protein 1 Gene Promotes Angiogenesis Through the Transactivation of Both Vascular Endothelial Growth Factor and Its Receptor, Flt-1
2004
Role of Endothelial Dysfunction in Atherosclerosis
2004 Standout
Role of Akt Signaling in Vascular Homeostasis and Angiogenesis
2002
PTEN Activity Is Modulated During Ischemia and Reperfusion
2005 StandoutNobel
Pleiotropic Effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors
2001
Effects of Aging and Hypoxia-Inducible Factor-1 Activity on Angiogenic Cell Mobilization and Recovery of Perfusion After Limb Ischemia
2007 StandoutNobel
Pulmonary Arterial Hypertension
2006
Metabolic reprogramming by HIF-1 promotes the survival of bone marrow–derived angiogenic cells in ischemic tissue
2011 StandoutNobel
Glycogen Synthase Kinase-3 Mediates Endothelial Cell Activation by Tumor Necrosis Factor-α
2005
Akt-Dependent Phosphorylation of p21Cip1 Regulates PCNA Binding and Proliferation of Endothelial Cells
2001
PLEIOTROPIC EFFECTS OF STATINS
2004 Standout
Structural Mechanism for Statin Inhibition of HMG-CoA Reductase
2001 ScienceNobel
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Cellular Function of Phosphoinositide 3-Kinases: Implications for Development, Immunity, Homeostasis, and Cancer
2001
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment
2005
Statin Therapy Accelerates Reendothelialization
2002
Endothelial Progenitor Cells
2004 Standout
Hypoxic retinal Müller cells promote vascular permeability by HIF-1–dependent up-regulation of angiopoietin-like 4
2013 StandoutNobel
Activation of the Unfolded Protein Response Occurs at All Stages of Atherosclerotic Lesion Development in Apolipoprotein E–Deficient Mice
2005
Treatment With Statins After Induction of Focal Ischemia in Rats Reduces the Extent of Brain Damage
2003
Synergistic effect of HIF-1α gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia
2009 StandoutNobel
Explaining the Phenomenon of Nitrate Tolerance
2005
Adenoviral transfer of HIF-1α enhances vascular responses to critical limb ischemia in diabetic mice
2009 StandoutNobel
Effect of Simvastatin and Antioxidant Vitamins on Atrial Fibrillation Promotion by Atrial-Tachycardia Remodeling in Dogs
2004
THE REGULATION AND PHARMACOLOGY OF ENDOTHELIAL NITRIC OXIDE SYNTHASE
2005
Statin Treatment and Stroke Outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial
2009
Post-Translational Control of Endothelial Nitric Oxide Synthase: Why Isn't Calcium/Calmodulin Enough?
2001
ANGPTL4 modulates vascular junction integrity by integrin signaling and disruption of intercellular VE-cadherin and claudin-5 clusters
2011
Increase in Circulating Endothelial Progenitor Cells by Statin Therapy in Patients With Stable Coronary Artery Disease
2001
Works of Ann Bialik being referenced
The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.
2000
Regulation of Angiogenesis by Glycogen Synthase Kinase-3β
2002
Glycogen-Synthase Kinase3β/β-Catenin Axis Promotes Angiogenesis Through Activation of Vascular Endothelial Growth Factor Signaling in Endothelial Cells
2005
Endothelial Overexpression of Fas Ligand Decreases Atherosclerosis in Apolipoprotein E–Deficient Mice
2004